These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 30771406)
1. Identification of small molecule inhibitors targeting the Zika virus envelope protein. Pitts J; Hsia CY; Lian W; Wang J; Pfeil MP; Kwiatkowski N; Li Z; Jang J; Gray NS; Yang PL Antiviral Res; 2019 Apr; 164():147-153. PubMed ID: 30771406 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein. Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735 [TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein. Sharma N; Prosser O; Kumar P; Tuplin A; Giri R Antiviral Res; 2020 Oct; 182():104876. PubMed ID: 32783901 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein. de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406 [TBL] [Abstract][Full Text] [Related]
5. Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E. Telehany SM; Humby MS; McGee TD; Riley SP; Jacobs A; Rizzo RC Biochemistry; 2020 Oct; 59(39):3709-3724. PubMed ID: 32876433 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay. Adcock RS; Chu YK; Golden JE; Chung DH Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709 [TBL] [Abstract][Full Text] [Related]
7. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion. Yamamoto M; Ichinohe T; Watanabe A; Kobayashi A; Zhang R; Song J; Kawaguchi Y; Matsuda Z; Inoue JI Viruses; 2020 Dec; 12(12):. PubMed ID: 33371476 [TBL] [Abstract][Full Text] [Related]
8. The Race To Find Antivirals for Zika Virus. Saiz JC; Martín-Acebes MA Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348160 [TBL] [Abstract][Full Text] [Related]
9. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577 [TBL] [Abstract][Full Text] [Related]
10. Envelope Protein-Targeting Zika Virus Entry Inhibitors. Roy A; Liu Q; Yang Y; Debnath AK; Du L Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273370 [TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection. Loe MWC; Lee RCH; Chu JJH Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333 [TBL] [Abstract][Full Text] [Related]
12. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo. Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640 [TBL] [Abstract][Full Text] [Related]
13. Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus. Rausch K; Hackett BA; Weinbren NL; Reeder SM; Sadovsky Y; Hunter CA; Schultz DC; Coyne CB; Cherry S Cell Rep; 2017 Jan; 18(3):804-815. PubMed ID: 28099856 [TBL] [Abstract][Full Text] [Related]
14. Novel Nucleoside Analogues as Effective Antiviral Agents for Zika Virus Infections. Bassetto M; Cima CM; Basso M; Salerno M; Schwarze F; Friese D; Bugert JJ; Brancale A Molecules; 2020 Oct; 25(20):. PubMed ID: 33092055 [TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus. Pitts JD; Li PC; de Wispelaere M; Yang PL Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080 [TBL] [Abstract][Full Text] [Related]
16. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach. Aarthy M; Singh SK Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716 [TBL] [Abstract][Full Text] [Related]
17. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane. Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562 [TBL] [Abstract][Full Text] [Related]
18. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference. Sze A; Olagnier D; Hadj SB; Han X; Tian XH; Xu HT; Yang L; Shi Q; Wang P; Wainberg MA; Wu JH; Lin R Viruses; 2017 Oct; 9(10):. PubMed ID: 28972551 [TBL] [Abstract][Full Text] [Related]
19. Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry. Mazzon M; Ortega-Prieto AM; Imrie D; Luft C; Hess L; Czieso S; Grove J; Skelton JK; Farleigh L; Bugert JJ; Wright E; Temperton N; Angell R; Oxenford S; Jacobs M; Ketteler R; Dorner M; Marsh M Viruses; 2019 Feb; 11(2):. PubMed ID: 30791609 [TBL] [Abstract][Full Text] [Related]
20. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus. Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]